Home > Balance Sheet > CONCORD BIOTECH

CONCORD BIOTECH
Total Non-Current Liabilities

    Back to Balance Sheet
CONCORD BIOTECH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

CONCORD BIOTECH Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Non-Current Liabilities ₹37 Cr₹32 Cr₹32 Cr₹54 Cr₹77 Cr

What is the latest Total Non-Current Liabilities ratio of CONCORD BIOTECH ?

The latest Total Non-Current Liabilities ratio of CONCORD BIOTECH is ₹37 Cr based on Mar2025 Consolidated results.
Year Total Non-Current Liabilities
Mar2025₹37 Cr
Mar2024₹32 Cr
Mar2023₹32 Cr
Mar2022₹54 Cr
Mar2021₹77 Cr

How is Total Non-Current Liabilities of CONCORD BIOTECH Trending?

Years Total Non-Current Liabilities % Change
Mar2025 ₹37 Cr
17.43
Mar2024 ₹32 Cr
-0.71
Mar2023 ₹32 Cr
-40.93
Mar2022 ₹54 Cr
-29.74
Mar2021 ₹77 Cr -

Compare Total Non-Current Liabilities of peers of CONCORD BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CONCORD BIOTECH ₹11,276.9 Cr -6.2% -12% -37.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹415,217.0 Cr 0.4% 5.6% 1.8% Stock Analytics
DIVIS LABORATORIES ₹166,047.0 Cr -0.5% 3.3% 7.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹148,872.0 Cr 4.5% 10% 41.5% Stock Analytics
DR REDDYS LABORATORIES ₹108,454.0 Cr 1.5% 4.8% 9.1% Stock Analytics
CIPLA ₹107,136.0 Cr -1.7% 1% -10.5% Stock Analytics


CONCORD BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CONCORD BIOTECH

-6.2%

-12%

-37.7%

SENSEX

-1.5%

0.8%

8.2%


You may also like the below Video Courses